Detailed answers about TAUC3 BIOLOGICS LIMITED, including incorporation, status, business activity, and accounts information.
When was TAUC3 BIOLOGICS LIMITED founded?
TAUC3 BIOLOGICS LIMITED was officially incorporated on 19 July 2019 and is registered under company number 12112647. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is TAUC3 BIOLOGICS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of TAUC3 BIOLOGICS LIMITED?
TAUC3 BIOLOGICS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does TAUC3 BIOLOGICS LIMITED do?
TAUC3 BIOLOGICS LIMITED operates in the following sector: 72190 - Other research and experimental development on natural sciences and engineering. This provides insight into the company's primary business activity and industry focus.
What is TAUC3 BIOLOGICS LIMITED's registered address?
The registered office address of TAUC3 BIOLOGICS LIMITED is 5 NEW STREET SQUARE, LONDON, UNITED KINGDOM, EC4A 3TW. This is the official address filed with Companies House for legal and statutory correspondence.
Is TAUC3 BIOLOGICS LIMITED financially stable?
The most recent accounts for TAUC3 BIOLOGICS LIMITED were made up to 31 December 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 30 September 2026.
Does TAUC3 BIOLOGICS LIMITED have any charges or mortgages?
TAUC3 BIOLOGICS LIMITED has 2 registered charges, of which 1 is outstanding, 1 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.